Laparoscopic Approach to Cancer of the Endometrium
LACE - Laparoscopic Approach to Cancer of the Endometrium: An International Multicenter Randomized Phase 3 Clinical Trial
Sponsor: Cancer Australia
This PHASE3 trial investigates Endometrial Cancer and is currently completed. Cancer Australia leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Apr 2019 — Jan 2021 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE3
▶ Show 2 earlier versions
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — May 2018 [monthly]
Active Not Recruiting PHASE3
First recorded
Oct 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Australia
- Cancer Council New South Wales
- Cancer Council Queensland
- Cancer Council Victoria
- Cancer Council Western Australia
- Gynetech
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- National Health and Medical Research Council, Australia
- Queensland Centre for Gynaecological Cancer
- Queensland Government - Smart Health Research Grant
- Tyco Healthcare Group
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Adelaide, Australia, Auchenflower, Australia, Box Hill, Australia, Camperdown, Australia, Carlton, Australia, Christchurch, New Zealand, Clayton, Australia, Edinburgh, United Kingdom, Greenslopes, Australia, Herston, Australia and 11 more location s